Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Corrigendum to "Considerations and quality controls when analyzing cell-free tumor DNA" [Biomol. Detect. Quantif. 17 (2019) 100078].

Johansson G, Andersson D, Filges S, Li J, Muth A, Godfrey TE, Ståhlberg A.

Biomol Detect Quantif. 2019 Jun 18;17:100091. doi: 10.1016/j.bdq.2019.100091. eCollection 2019 Mar.

2.

Drug repurposing: a promising tool to accelerate the drug discovery process.

Parvathaneni V, Kulkarni NS, Muth A, Gupta V.

Drug Discov Today. 2019 Jun 22. pii: S1359-6446(18)30259-9. doi: 10.1016/j.drudis.2019.06.014. [Epub ahead of print] Review.

PMID:
31238113
3.

Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment.

Kulkarni NS, Parvathaneni V, Shukla SK, Barasa L, Perron JC, Yoganathan S, Muth A, Gupta V.

Eur J Pharm Sci. 2019 May 15;133:145-159. doi: 10.1016/j.ejps.2019.03.026. Epub 2019 Apr 1.

PMID:
30946965
4.

Considerations and quality controls when analyzing cell-free tumor DNA.

Johansson G, Andersson D, Filges S, Li J, Muth A, Godfrey TE, Ståhlberg A.

Biomol Detect Quantif. 2019 Feb 13;17:100078. doi: 10.1016/j.bdq.2018.12.003. eCollection 2019 Mar. Erratum in: Biomol Detect Quantif. 2019 Jun 18;17:100091.

5.

Microtargeting for conservation.

Metcalf AL, Phelan CN, Pallai C, Norton M, Yuhas B, Finley JC, Muth A.

Conserv Biol. 2019 Mar 18. doi: 10.1111/cobi.13315. [Epub ahead of print]

PMID:
30887584
6.

A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer.

Sebastian M, Schröder A, Scheel B, Hong HS, Muth A, von Boehmer L, Zippelius A, Mayer F, Reck M, Atanackovic D, Thomas M, Schneller F, Stöhlmacher J, Bernhard H, Gröschel A, Lander T, Probst J, Strack T, Wiegand V, Gnad-Vogt U, Kallen KJ, Hoerr I, von der Muelbe F, Fotin-Mleczek M, Knuth A, Koch SD.

Cancer Immunol Immunother. 2019 May;68(5):799-812. doi: 10.1007/s00262-019-02315-x. Epub 2019 Feb 15.

PMID:
30770959
7.

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer.

Papachristofilou A, Hipp MM, Klinkhardt U, Früh M, Sebastian M, Weiss C, Pless M, Cathomas R, Hilbe W, Pall G, Wehler T, Alt J, Bischoff H, Geißler M, Griesinger F, Kallen KJ, Fotin-Mleczek M, Schröder A, Scheel B, Muth A, Seibel T, Stosnach C, Doener F, Hong HS, Koch SD, Gnad-Vogt U, Zippelius A.

J Immunother Cancer. 2019 Feb 8;7(1):38. doi: 10.1186/s40425-019-0520-5.

8.

Don't Get Stuck: A Quality Improvement Project to Reduce Perioperative Blood-Borne Pathogen Exposure.

Gurria JP, Nolan H, Polites S, Threlkeld M, Arata K, Phipps L, Muth A, Falcone RA Jr.

Jt Comm J Qual Patient Saf. 2019 May;45(5):329-336. doi: 10.1016/j.jcjq.2018.12.002. Epub 2019 Feb 4.

PMID:
30733139
9.

Recruitment tolerance to increased temperature present across multiple kelp clades.

Muth AF, Graham MH, Lane CE, Harley CDG.

Ecology. 2019 Mar;100(3):e02594. doi: 10.1002/ecy.2594.

PMID:
30615200
10.

Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma.

Muth A, Crona J, Gimm O, Elmgren A, Filipsson K, Stenmark Askmalm M, Sandstedt J, Tengvar M, Tham E.

J Intern Med. 2019 Feb;285(2):187-204. doi: 10.1111/joim.12869. Epub 2019 Jan 15. Review.

PMID:
30536464
11.

Colorectal cancer liver metastatic growth depends on PAD4-driven citrullination of the extracellular matrix.

Yuzhalin AE, Gordon-Weeks AN, Tognoli ML, Jones K, Markelc B, Konietzny R, Fischer R, Muth A, O'Neill E, Thompson PR, Venables PJ, Kessler BM, Lim SY, Muschel RJ.

Nat Commun. 2018 Nov 14;9(1):4783. doi: 10.1038/s41467-018-07306-7.

12.

Total versus subtotal parathyroidectomy for secondary hyperparathyroidism.

Isaksson E, Ivarsson K, Akaberi S, Muth A, Prütz KG, Clyne N, Sterner G, Almquist M.

Surgery. 2019 Jan;165(1):142-150. doi: 10.1016/j.surg.2018.04.076. Epub 2018 Nov 7.

PMID:
30413319
13.

Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer.

Vaidya B, Parvathaneni V, Kulkarni NS, Shukla SK, Damon JK, Sarode A, Kanabar D, Garcia JV, Mitragotri S, Muth A, Gupta V.

Int J Biol Macromol. 2019 Feb 1;122:338-347. doi: 10.1016/j.ijbiomac.2018.10.181. Epub 2018 Oct 26.

PMID:
30401652
14.

Nintedanib-cyclodextrin complex to improve bio-activity and intestinal permeability.

Vaidya B, Shukla SK, Kolluru S, Huen M, Mulla N, Mehra N, Kanabar D, Palakurthi S, Ayehunie S, Muth A, Gupta V.

Carbohydr Polym. 2019 Jan 15;204:68-77. doi: 10.1016/j.carbpol.2018.09.080. Epub 2018 Oct 4.

PMID:
30366544
15.

Histone Citrullination Represses MicroRNA Expression, Resulting in Increased Oncogene mRNAs in Somatolactotrope Cells.

DeVore SB, Young CH, Li G, Sundararajan A, Ramaraj T, Mudge J, Schilkey F, Muth A, Thompson PR, Cherrington BD.

Mol Cell Biol. 2018 Sep 14;38(19). pii: e00084-18. doi: 10.1128/MCB.00084-18. Print 2018 Oct 1.

16.

BB-Cl-Amidine as a novel therapeutic for canine and feline mammary cancer via activation of the endoplasmic reticulum stress pathway.

Ledet MM, Anderson R, Harman R, Muth A, Thompson PR, Coonrod SA, Van de Walle GR.

BMC Cancer. 2018 Apr 12;18(1):412. doi: 10.1186/s12885-018-4323-8.

17.

The Development of Benzimidazole-Based Clickable Probes for the Efficient Labeling of Cellular Protein Arginine Deiminases (PADs).

Nemmara VV, Subramanian V, Muth A, Mondal S, Salinger AJ, Maurais AJ, Tilvawala R, Weerapana E, Thompson PR.

ACS Chem Biol. 2018 Mar 16;13(3):712-722. doi: 10.1021/acschembio.7b00957. Epub 2018 Feb 1.

18.

Infants born with critical CHD in Arizona and capacities of birth centres for screening and management.

Villa L, Bjornsen B, Giacone H, Weidler EM, Bajaj E, Muth A, Kennedy M, Flood T, Contreras D, Spadafino J, Shah A.

Cardiol Young. 2018 Feb;28(2):276-283. doi: 10.1017/S1047951117001901. Epub 2017 Oct 11.

PMID:
29017631
19.

[Swedish guidelines for the management of adrenal incidentalomas].

Muth A, Hammarstedt L, Hellström M, Nyman U, Sundin A, Wahrenberg H, Wängberg B.

Lakartidningen. 2017 Sep 29;114. pii: ETD6. Review. Swedish.

20.

PAD1 promotes epithelial-mesenchymal transition and metastasis in triple-negative breast cancer cells by regulating MEK1-ERK1/2-MMP2 signaling.

Qin H, Liu X, Li F, Miao L, Li T, Xu B, An X, Muth A, Thompson PR, Coonrod SA, Zhang X.

Cancer Lett. 2017 Nov 28;409:30-41. doi: 10.1016/j.canlet.2017.08.019. Epub 2017 Aug 24.

21.

Covalent coupling of high-affinity ligands to the surface of viral vector particles by protein trans-splicing mediates cell type-specific gene transfer.

Muik A, Reul J, Friedel T, Muth A, Hartmann KP, Schneider IC, Münch RC, Buchholz CJ.

Biomaterials. 2017 Nov;144:84-94. doi: 10.1016/j.biomaterials.2017.07.032. Epub 2017 Jul 25.

PMID:
28825979
22.

Citrullination of NF-κB p65 promotes its nuclear localization and TLR-induced expression of IL-1β and TNFα.

Sun B, Dwivedi N, Bechtel TJ, Paulsen JL, Muth A, Bawadekar M, Li G, Thompson PR, Shelef MA, Schiffer CA, Weerapana E, Ho IC.

Sci Immunol. 2017 Jun 9;2(12). pii: eaal3062. doi: 10.1126/sciimmunol.aal3062.

23.

Diverse stimuli engage different neutrophil extracellular trap pathways.

Kenny EF, Herzig A, Krüger R, Muth A, Mondal S, Thompson PR, Brinkmann V, Bernuth HV, Zychlinsky A.

Elife. 2017 Jun 2;6. pii: e24437. doi: 10.7554/eLife.24437.

24.

Exploitation of Novel Molecular Targets to Treat Idiopathic Pulmonary Fibrosis: A Drug Discovery Perspective.

Vaidya B, Patel R, Muth A, Gupta V.

Curr Med Chem. 2017;24(22):2439-2458. doi: 10.2174/0929867324666170526123607. Review.

PMID:
28552057
25.

The Effect of Parathyroidectomy on Risk of Hip Fracture in Secondary Hyperparathyroidism.

Isaksson E, Ivarsson K, Akaberi S, Muth A, Sterner G, Karl-Göran P, Clyne N, Almquist M.

World J Surg. 2017 Sep;41(9):2304-2311. doi: 10.1007/s00268-017-4000-0.

26.

Development of a Selective Inhibitor of Protein Arginine Deiminase 2.

Muth A, Subramanian V, Beaumont E, Nagar M, Kerry P, McEwan P, Srinath H, Clancy K, Parelkar S, Thompson PR.

J Med Chem. 2017 Apr 13;60(7):3198-3211. doi: 10.1021/acs.jmedchem.7b00274. Epub 2017 Mar 31.

27.

Motuporamine Derivatives as Antimicrobial Agents and Antibiotic Enhancers against Resistant Gram-Negative Bacteria.

Borselli D, Blanchet M, Bolla JM, Muth A, Skruber K, Phanstiel O 4th, Brunel JM.

Chembiochem. 2017 Feb 1;18(3):276-283. doi: 10.1002/cbic.201600532. Epub 2017 Jan 18.

28.

Citrullination regulates the expression of insulin-like growth factor-binding protein 1 (IGFBP1) in ovine uterine luminal epithelial cells.

Young CH, Rothfuss HM, Gard PF, Muth A, Thompson PR, Ashley RL, Cherrington BD.

Reproduction. 2017 Jan;153(1):1-10. doi: 10.1530/REP-16-0494. Epub 2016 Oct 10.

29.

Peptidylarginine deiminase 1-catalyzed histone citrullination is essential for early embryo development.

Zhang X, Liu X, Zhang M, Li T, Muth A, Thompson PR, Coonrod SA, Zhang X.

Sci Rep. 2016 Dec 8;6:38727. doi: 10.1038/srep38727.

30.

Hypoparathyroidism after total thyroidectomy in patients with previous gastric bypass.

Droeser RA, Ottosson J, Muth A, Hultin H, Lindwall-Åhlander K, Bergenfelz A, Almquist M.

Langenbecks Arch Surg. 2017 Mar;402(2):273-280. doi: 10.1007/s00423-016-1517-x. Epub 2016 Oct 26.

31.

GnRH Stimulates Peptidylarginine Deiminase Catalyzed Histone Citrullination in Gonadotrope Cells.

Khan SA, Edwards BS, Muth A, Thompson PR, Cherrington BD, Navratil AM.

Mol Endocrinol. 2016 Oct;30(10):1081-1091. Epub 2016 Sep 7.

32.

Receptor-Targeted Nipah Virus Glycoproteins Improve Cell-Type Selective Gene Delivery and Reveal a Preference for Membrane-Proximal Cell Attachment.

Bender RR, Muth A, Schneider IC, Friedel T, Hartmann J, Plückthun A, Maisner A, Buchholz CJ.

PLoS Pathog. 2016 Jun 9;12(6):e1005641. doi: 10.1371/journal.ppat.1005641. eCollection 2016 Jun.

33.

Development of Glucose Regulated Protein 94-Selective Inhibitors Based on the BnIm and Radamide Scaffold.

Crowley VM, Khandelwal A, Mishra S, Stothert AR, Huard DJ, Zhao J, Muth A, Duerfeldt AS, Kizziah JL, Lieberman RL, Dickey CA, Blagg BS.

J Med Chem. 2016 Apr 14;59(7):3471-88. doi: 10.1021/acs.jmedchem.6b00085. Epub 2016 Apr 4.

34.

Citrullination-acetylation interplay guides E2F-1 activity during the inflammatory response.

Ghari F, Quirke AM, Munro S, Kawalkowska J, Picaud S, McGouran J, Subramanian V, Muth A, Williams R, Kessler B, Thompson PR, Fillipakopoulos P, Knapp S, Venables PJ, La Thangue NB.

Sci Adv. 2016 Feb 5;2(2):e1501257. doi: 10.1126/sciadv.1501257. eCollection 2016 Feb.

35.

Peptidylarginine Deiminase 3 (PAD3) Is Upregulated by Prolactin Stimulation of CID-9 Cells and Expressed in the Lactating Mouse Mammary Gland.

Li G, Hayward IN, Jenkins BR, Rothfuss HM, Young CH, Nevalainen MT, Muth A, Thompson PR, Navratil AM, Cherrington BD.

PLoS One. 2016 Jan 22;11(1):e0147503. doi: 10.1371/journal.pone.0147503. eCollection 2016.

36.

Malignant pheochromocytomas/paragangliomas harbor mutations in transport and cell adhesion genes.

Wilzén A, Rehammar A, Muth A, Nilsson O, Tešan Tomić T, Wängberg B, Kristiansson E, Abel F.

Int J Cancer. 2016 May 1;138(9):2201-11. doi: 10.1002/ijc.29957. Epub 2015 Dec 30.

37.

[Primary aldosteronism is an underdiagnosed cause of hypertension. Important to find undiagnosed patients--effective treatment available].

Ragnarsson O, Muth A, Johannsson G, Wängberg B.

Lakartidningen. 2015 Dec 1;112. pii: DRFR. Review. Swedish.

38.

[The importance of adrenal vein sampling in primary aldosteronism. Necessary examination for many patients as computed tomography can lead to errors].

Ragnarsson O, Wängberg B, Muth A, Sakinis A, Johannsson G.

Lakartidningen. 2015 Feb 10;112. pii: C97U. Swedish.

39.

Exclusive Transduction of Human CD4+ T Cells upon Systemic Delivery of CD4-Targeted Lentiviral Vectors.

Zhou Q, Uhlig KM, Muth A, Kimpel J, Lévy C, Münch RC, Seifried J, Pfeiffer A, Trkola A, Coulibaly C, von Laer D, Wels WS, Hartwig UF, Verhoeyen E, Buchholz CJ.

J Immunol. 2015 Sep 1;195(5):2493-501. doi: 10.4049/jimmunol.1500956. Epub 2015 Jul 31.

40.

Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.

Uhlig KM, Schülke S, Scheuplein VA, Malczyk AH, Reusch J, Kugelmann S, Muth A, Koch V, Hutzler S, Bodmer BS, Schambach A, Buchholz CJ, Waibler Z, Scheurer S, Mühlebach MD.

J Virol. 2015 Sep;89(17):9044-60. doi: 10.1128/JVI.00844-15. Epub 2015 Jun 17.

41.

Receptor-targeted lentiviral vectors are exceptionally sensitive toward the biophysical properties of the displayed single-chain Fv.

Friedel T, Hanisch LJ, Muth A, Honegger A, Abken H, Plückthun A, Buchholz CJ, Schneider IC.

Protein Eng Des Sel. 2015 Apr;28(4):93-106. doi: 10.1093/protein/gzv005. Epub 2015 Feb 25.

42.

Off-target-free gene delivery by affinity-purified receptor-targeted viral vectors.

Münch RC, Muth A, Muik A, Friedel T, Schmatz J, Dreier B, Trkola A, Plückthun A, Büning H, Buchholz CJ.

Nat Commun. 2015 Feb 10;6:6246. doi: 10.1038/ncomms7246.

PMID:
25665714
43.

Systematic review of surgery and outcomes in patients with primary aldosteronism.

Muth A, Ragnarsson O, Johannsson G, Wängberg B.

Br J Surg. 2015 Mar;102(4):307-17. doi: 10.1002/bjs.9744. Epub 2015 Jan 20. Review.

PMID:
25605481
44.

Computed tomography for preoperative evaluation of need for sternotomy in surgery for retrosternal goitre.

Malvemyr P, Liljeberg N, Hellström M, Muth A.

Langenbecks Arch Surg. 2015 Apr;400(3):293-9. doi: 10.1007/s00423-014-1268-5. Epub 2015 Jan 4.

PMID:
25557494
45.

Development of radamide analogs as Grp94 inhibitors.

Muth A, Crowley V, Khandelwal A, Mishra S, Zhao J, Hall J, Blagg BS.

Bioorg Med Chem. 2014 Aug 1;22(15):4083-98. doi: 10.1016/j.bmc.2014.05.075. Epub 2014 Jun 12.

46.

Visuo-spatial performance in autism: a meta-analysis.

Muth A, Hönekopp J, Falter CM.

J Autism Dev Disord. 2014 Dec;44(12):3245-63. doi: 10.1007/s10803-014-2188-5.

PMID:
25022252
47.

Environmental stressors influencing hormones and systems physiology in cattle.

Bova TL, Chiavaccini L, Cline GF, Hart CG, Matheny K, Muth AM, Voelz BE, Kesler D, Memili E.

Reprod Biol Endocrinol. 2014 Jul 4;12:58. doi: 10.1186/1477-7827-12-58. Review.

48.

Synthesis and biological evaluation of antimetastatic agents predicated upon dihydromotuporamine C and its carbocyclic derivatives.

Muth A, Pandey V, Kaur N, Wason M, Baker C, Han X, Johnson TR, Altomare DA, Phanstiel O 4th.

J Med Chem. 2014 May 22;57(10):4023-34. doi: 10.1021/jm401906v. Epub 2014 May 2.

PMID:
24784222
49.

Polyamine transport inhibitors: design, synthesis, and combination therapies with difluoromethylornithine.

Muth A, Madan M, Archer JJ, Ocampo N, Rodriguez L, Phanstiel O 4th.

J Med Chem. 2014 Jan 23;57(2):348-63. doi: 10.1021/jm401174a. Epub 2014 Jan 9.

PMID:
24405276
50.

Development of polyamine transport ligands with improved metabolic stability and selectivity against specific human cancers.

Muth A, Kamel J, Kaur N, Shicora AC, Ayene IS, Gilmour SK, Phanstiel O 4th.

J Med Chem. 2013 Jul 25;56(14):5819-28. doi: 10.1021/jm400496a. Epub 2013 Jul 10.

PMID:
23841465

Supplemental Content

Support Center